Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)

$53,986K23FY2020NRNIH

Ohio State University, Columbus OH

Investigators

Shannon L. Gillespiecontact

Linked publications, trials & patents

Paper 35031400 Paper 34173372 Paper 32332443 Paper 31815157 Paper 31307010 Paper 31248628 Paper 30515434

Abstract

Project Summary/Abstract Not applicable for supplement application

View original record on NIH RePORTER →

Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL) · GrantIndex